ÂÜÀòÂÒÂ×

Elizabeth Klatt is a Senior Manager in Pharmaceutical Development CMC at Orna Therapeutics, having started in August 2023. Prior to this role, Elizabeth served as QC Operations Manager at FUJIFILM Diosynth Biotechnologies from April 2022 to August 2023 and as Quality Control Manager at Esperion from July 2021 to April 2022, where responsibilities included providing technical guidance and reviewing quality control data. Elizabeth has held various positions at PPD, including Senior Group Leader and Senior Scientist, overseeing laboratory operations and method development. Earlier experience includes roles at Catalent Pharma Solutions, focusing on stability programs, and a significant tenure at Yogi Bear's Jellystone Camp Resort. Elizabeth holds a Master of Science in Biotechnology from the University of Wisconsin-Madison and a Bachelor of Science in Biochemistry from the University of Wisconsin-La Crosse.